Fangzhou Inc. provides online chronic disease management services in China. It operates through four segments: Online Retail Pharmacy Services; Comprehensive Medical Services; Wholesale; and Customized Content and Marketing Solutions. The company offers services through online chronic disease management platform to address the needs of patients with chronic disease, such as hypertension, cardiovascular and respiratory diseases. It also engages in the sales of pharmaceutical and healthcare products through online retail pharmacy service platform, third-party platforms, and offline retail pharmacies; and online consultation, e-prescription, physician consultation, physical examination, and surgery service, as well as wholesale of pharmaceutical products. Fangzhou Inc. was founded in 2015 and is based in Guangzhou, China.
Frequently asked questions
What sector does Fangzhou Inc (6086) operate in?
Fangzhou Inc belongs to the Other sector and operates in the Pharmaceutical Retailers industry.
What is Fangzhou Inc (6086) current stock price?
As of the latest data, Fangzhou Inc stock price is HK$0.92, with a previous close of HK$0.91. Fangzhou Inc gained HK$0.01 in the last trading session, representing a 0.55% increase.
What is Fangzhou Inc (6086) current market capitalization?
Fangzhou Inc market cap is approximately 1.27 billion.
What is Fangzhou Inc (6086) EBITDA?
Fangzhou Inc EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) is 10.94 million.
Does Fangzhou Inc (6086) pay dividends?
No. Fangzhou Inc does not pay a dividend.
What is Fangzhou Inc (6086) beta (volatility) score?
Fangzhou Inc has a beta of 0.530, indicating lower volatility than the overall market.